Home > Boards > US OTC > Biotechs > VistaGen Therapeutics, Inc. (VTGN)

How do you know that?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
dg33 Member Profile
 
Followed By 8
Posts 655
Boards Moderated 0
Alias Born 02/23/17
160x600 placeholder
VistaGen initiates late-stage trial of PH94B in social anxiety disorder Seeking Alpha - 5/26/2021 8:36:34 AM
VistaGen Therapeutics Initiates PALISADE Phase 3 Trial of PH94B in Social Anxiety Disorder GlobeNewswire Inc. - 5/26/2021 8:00:00 AM
VistaGen Therapeutics to Present at Two Investor Conferences in June GlobeNewswire Inc. - 5/20/2021 8:00:00 AM
VistaGen surges 17% post-market after Baird calls stock 'significantly undervalued' Seeking Alpha - 5/19/2021 4:48:15 PM
VistaGen Therapeutics files for $75M at-the-market offering Seeking Alpha - 5/14/2021 5:16:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2021 4:10:26 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/14/2021 4:07:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/4/2021 4:40:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/4/2021 4:36:54 PM
VistaGen names new chief commercial officer Seeking Alpha - 5/4/2021 8:24:38 AM
VistaGen Therapeutics Announces Appointment of Ann Cunningham as Chief Commercial Officer GlobeNewswire Inc. - 5/4/2021 8:00:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/29/2021 10:17:38 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/27/2021 4:14:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/27/2021 4:12:29 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/27/2021 4:12:14 PM
VistaGen Therapeutics Announces Appointment of Joanne Curley, Ph.D. to its Board of Directors GlobeNewswire Inc. - 4/27/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/26/2021 5:19:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/22/2021 7:06:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/22/2021 7:03:44 PM
VistaGen’s Poster Presentation at the Anxiety and Depression Association of America’s 2021 Annual Conference Differentiat... GlobeNewswire Inc. - 3/22/2021 8:30:00 AM
VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March GlobeNewswire Inc. - 3/16/2021 7:46:12 AM
VistaGen Therapeutics files for $250M mixed shelf Seeking Alpha - 3/16/2021 2:52:46 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 3/15/2021 5:01:54 PM
VistaGen’s PH10 Nasal Spray Demonstrates Different Mechanism of Action from Benzodiazepines in Preclinical Study GlobeNewswire Inc. - 3/11/2021 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/5/2021 4:43:55 PM
dg33   Thursday, 12/17/20 11:30:32 PM
Re: jimmy667 post# 4513
Post # of 4711 
How do you know that?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences